Pharmacological and environmental determinants of relapse to cocaine-seeking behavior

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 2, 1999, Pages 327-336

  Spealman, R D ^a   Barrett Larimore, R L ^a   Rowlett, J K ^a   Platt, D M ^a   Khroyan, T V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cocaine; D1 and D2 like receptor mechanisms; Dopamine agonists and antagonists; Drug cues; Drug priming; Medications development; Reinstatement; Relapse; Stress

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4,4A,10B TETRAHYDRO 4 PROPYL 2H,5H [1]BENZOPYRANO[4,3 B][1,4]OXAZIN 9 OL; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; AMPHETAMINE; APOMORPHINE; BROMOCRIPTINE; CAFFEINE; COCAINE; DIAMORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ECOPIPAM; EMONAPRIDE; ETICLOPRIDE; ETONITAZENE; METHAMPHETAMINE; MORPHINE; N (1 BENZYL 3 PYRROLIDINYL) 5 CHLORO 4 CYCLOPROPYLCARBOXAMIDO 2 METHOXYBENZAMIDE; PARTIAL AGONIST; PROPYLNORAPOMORPHINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; BEHAVIOR; COCAINE DEPENDENCE; CONFERENCE PAPER; DISCRIMINATIVE STIMULUS; DRUG SELF ADMINISTRATION; ENVIRONMENTAL FACTOR; HUMAN; NONHUMAN; PRIORITY JOURNAL; RELAPSE; WITHDRAWAL SYNDROME;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; HUMANS; RATS; RECURRENCE; SOCIAL ENVIRONMENT;

ANIMALIA;

EID: 0032844001     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00049-0     Document Type: Conference Paper

References (102)

1. 3 receptor ligands. Eur. J. Pharmacol. 281:1995;R7-R9.
2. Ahmed S.H., Koob G.F. Cocaine- but not food-seeking behavior is reinstated by stress after prolonged extinction. Psychopharmacology (Berlin). 132:1997;289-295.
3. 3 receptor antgagonist (+)-S 14297, nafadotride, GR 103,691 and U 99194. J. Pharmacol. Exp. Ther. 287:1998;187-197.
4. Barrett-Larimore R.L., Spealman R.D. Reinstatement of cocaine-seeking behavior in a nonhuman primate model of relapse. Soc. Neurosci. Abstr. 22:1996;925.
5. 3 agonists. In: Problems of drug dependence 1997; NIDA Research Monograph. Washington, DC: U.S. Government Printing Office 178:283; 1998.
6. Barrot M., Rouge-Pont F., Maccari S., Marinelli M., Le Moal M., Piazza P.V. Glucocorticoids and drug abuse (III). Influences of basal corticosterone secretion on the effects of cocaine and morphine on accumbens dopamine. Soc. Neurosci. Abstr. 20:1994;1633.
7. 2 antagonists. Behav. Pharmacol. 1:1990;355-363.
8. Bergman J., Madras B., Johnson S.E., Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J. Pharmacol. Exp. Ther. 251:1989;150-155.
9. 2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J. Pharmacol. Exp. Ther. 273:1995;40-48.
10. 1 receptor ligands. Drug interaction studies in squirrel monkeys J. Pharmacol. Exp. Ther. 276:1996;942-950.
11. 1 dopamine receptor agonists induce forelimb clonus. Soc. Neurosci. Abstr. 17:1991;638.
12. 3 dopamine receptors. Science. 260:1993;1814-1816.
13. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218.
14. 2 dopamine agonists on cocaine discrimination and self-administration in rats. In: Problems of drug dependence 1998, NIDA Research Monograph. Washington, DC: U.S. Government Printing Office 179:87; 1999.
15. Carroll K.M., Rounsaville B.J., Nich C., Gordon L.T., Wirtz P.W., Gawin F. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Arch. Gen. Psychiatry. 51:1994;989-997.
16. Carroll M.E., Comer S.D. Animal models of relapse. Exp. Clin. Psychopharmacol. 1:1996;11-18.
17. Childress, A. R.; Hole, A. V.; Ehrman, R. N.; Robbins, S. J.; McLellan, A. T.; O'Brien, C. P.: Cue reactivity and cue reactivity interventions in drug dependence. In: Onken, L. S.; Blaine, J. D.; Boren, J. J., eds. Behavioral treatments of drug abuse and dependence. NIDA Res. Monogr. 137:73-95; 1993.
18. Childress, A. R.; McLellan, A. T.; Ehrman, R.; O'Brien, C. P.: Classically conditioned responses in opioid and cocaine dependence: A role in relapse? In: Ray, B. A., ed. Learning factors in substance abuse. NIDA Res. Monogr. 84:25-43; 1988.
19. Colpaert F.C., Niemegeers C.J.E., Janssen P.A.J. Discriminative stimulus properties of cocaine. Neuropharmacological characteristics as derived from stimulus generalization experiments Pharmacol. Biochem. Behav. 10:1972;535-546.
20. Comer S.A., Lac S.T., Curtis L.K., Carroll M.E. Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J. Pharmacol. Exp. Ther. 267:1993;1470-1474.
21. Davis M.W., Smith S.G. Role of conditioned reinforcers in the initiation, maintenance and extinction of drug-seeking behavior. Pav. J. Biol. Sci. 11:1976;222-236.
22. Deroche V., Marinelli M., Le Moal M., Piazza P.V. Glucocorticoids and behavioral effects of psychostimulants. II. Cocaine intravenous self-administration and reinstatement depend on glucocorticoid levels. J. Pharmacol. Exp. There. 281:1997;1401-1407.
23. deWit H., Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berlin). 75:1981;134-143.
24. deWit H., Stewart J. Drug reinstatement of heroin-reinforced responding in the rat. Psychopharmacology (Berlin). 79:1983;29-31.
25. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci USA. 85:1988;5274-5278.
26. Dunwiddie T.V., Fredholm B.B. Adenosine neuromodulation. Jacobson K.A., Jarvis M.F. Purinergic approaches in experimental therapeutics. 1997;359-382 Wiley-Liss, Inc, New York.
27. Erb S. Shaham, Y.; Stewart, J. Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period Psychopharmacology (Berlin). 128:1996;408-412.
28. Ferré S., Fuxe K., Von Euler G., Johansson B., Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512.
29. Fuchs R.A., Tran-Nguyen L.T.L., Specio S.E., Groff R.S., Neisewander J.L. Predictive validity of the extinction/reinstatement model of drug craving. Psychopharmacology (Berlin). 135:1998;151-160.
30. Gawin F.H. Cocaine addiction. Psychology and neurophysiology Science. 251:1991;1580-1586.
31. Gerber G.J., Stretch R. Drug-induced reinstatement of extinguished self-administration behavior in monkeys. Pharmacol. Biochem. Behav. 3:1975;1055-1061.
32. Glowa J.R., Wojnicki F.H.E., Matecka D., Bacher J.D., Mansbach R.S., Balster R.L., Rice K. Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding. I. Dependence on unit dose of cocaine Exp. Clin. Psychopharmacol. 3:1995;219-231.
33. Glowa J.R., Wojnicki F.H.E., Matecka D., Rice K., Rothman R.B. Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding. II. Comparisons with other drugs and repeated administrations Exp. Clin. Psychopharmacol. 3:1995;232-239.
34. Goldberg S.R. Stimuli associated with drug injection as events that control behaviour. Pharmacol. Rev. 27:1976;325-339.
35. Goldberg S.R., Kelleher R.T., Morse W.H. Second-order schedules of drug injection. Fed. Proc. 34:1975;1771-1776.
36. Goldberg S.R., Spealman R.D., Kelleher R.T. Enhancement of drug-seeking behavior by environmental stimuli associated with cocaine or morphine injections. Neuropharmacology. 18:1979;1015-1017.
37. Grabowski J., Schmitz J., Roache J.D., Rhoades H., Elk R., Creson D.L. Methylphenidate (MP) for initial treatment of cocaine dependence and a model for medications evaluation. Harris L.S. Problems of drug dependence, 1993, NIDA Monograph 141. 1994;436 U.S. Government Printing Office, Washington, DC.
38. 1 receptor agonists by squirrel monkeys. Psychopharmacology (Berlin). 125:1996;97-104.
39. Haney M., Fischman M.W., Foltin R.W. Effect of pergolide on cocaine self-administration in men and women. Psychopharmacology (Berlin). 137:1998;15-24.
40. Harland R.D., Gauvin D.V., Michaelis R.C., Carney J.M., Seale T.W., Holloway F.A. Behavioral interaction between cocaine and caffeine. A drug discrimination analysis in rats Pharmacol. Biochem. Behav. 32:1989;1017-1023.
41. Hartman D.S., Civelli O. Dopamine receptor diversity. Molecular and pharmacological perspectives Prog. Drug Res. 48:1997;173-194.
42. Jaffe J.H., Cascella N.G., Kumor K.M., Sherer M.A. Cocaine-induced cocaine craving. Psychopharmacology (Berlin). 97:1989;59-64.
43. Johanson C.-E., Schuster C.R. Cocaine. Bloom F.E., Kupfer D.J. Psychopharmacology. The fourth generation of progress:1995;1685-1698 Raven Press, New York.
44. 1-dopamine receptor antagonist SCH 39166 in acutely ill schizophrenic patients. Psychopharmacology (Berlin). 121:1995;309-316.
45. Khroyan T.V., Fuchs R.A., Baker D.A., Neisewander J.L. Effects of D3-preferring agonists 7-OH-PIPAT and PD-128,907 on motor behaviors and place conditioning. Behav. Pharmacol. 8:1997;65-74.
46. Khroyan, T. V.; Barrett-Larimore, R. L.; Rowlett, J. K.; Spealman, R. D.: Dopaminergic mechanisms in relapse to cocaine-seeking behavior: Receptor subtype selectivity and efficacy. Abstracts of the 61st annual meeting of the College on Problems of Drug Dependence. 75; 1999.
47. Kleber H.D. Pharmacotherapy, current and potential, for the treatment of cocaine dependence. Clin. Neuropharmacol. 18:1995;S96-S109.
48. Kleven M.S., Woolverton W.L. Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology (Berlin). 101:1990;208-213.
49. 1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
50. Kreek M.J. Rationale for maintenance pharmacotherapy of opiate dependence. O'Brien C.P., Jaffe J.H. Addictive states. 1992;205-230 Raven Press, New York.
51. Kuhar M.J., Ritz M.C., Boja J.W. The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci. 14:1991;299-302.
52. Kumor, K.; Sherer, M.; Jaffe, J.: Haloperidol-induced dystonia in cocaine addicts. Lancet II:1341-1342; 1986.
53. Lynch W.J., Heaser W.A., Carroll M.E. Effects of amphetamine, butorphanol, and morphine pretreatment on the maintenance and reinstatement of cocaine-reinforced responding. Exp. Clin. Psychopharmacol. 6:1998;255-263.
54. Malison, R. T.; Wright, S.; Sanacora, G.; Potenza, M.; Mechanic, K.; Haroon, E.; Carpenter, L.; Pelton, G.; Self, D.; Kosten, T.; Krystal, J.; Nestler, E.: The dopamine D1 receptor agonist ABT-431 reduces cocaine-induced craving in human cocaine abusers. Abstracts of the 60th annual meeting of the College on Problems of Drug Dependence. 87; 1998.
55. Martlett G.A., Gordon J.R., Relapse prevention Maintenance strategies in the treatment of addictive behaviors. 1985;Guilford Press, New York.
56. McCance E.F. Overview of potential treatment medications for cocaine dependence. Tai B., Chiang N., Bridge P. Medication development for the treatment of cocaine dependence. Issues in clinical efficacy trials. NIDA Research Monograph 175:1997;36-72 U.S. Government Printing Office, Washington, DC.
57. McLellan A.T., O'Brien C.P., Metzger D., Alterman A.I., Cornish J., Urschel H. How effective is substance abuse treatment compared to what? O'Brien C.P., Jaffe J.H. Addictive states. 1992;231-252 Raven Press, New York.
58. Meil W.M., See R.E. Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats. An animal model of relapse Behav. Pharmacol. 7:1996;754-763.
59. Mello N.K., Negus S.S. Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology. 14:1996;375-424.
60. Mendelson J.H., Mello N.K. Management of cocaine abuse and dependence. N. Engl. J Med. 334:1996;965-972.
61. O'Brien C.P., Childress A.R., McLellan T., Ehrman R. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addict. Behav. 15:1990;355-365.
62. O'Doherty F., Davies J.B. Is drug use a response to stress? Drug Alcohol Depend. 29:1987;97-106.
63. 2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. Pharmacol. Toxicol. 72:1993;213-220.
64. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., LeMoal M., Simon H. Reinforcing properties of corticosterone demonstrated by intravenous self-administration. Possible biological basis of sensation-seeking. Proc. Natl. Acad. Sci. USA. 90:1993;11738-11742.
65. Platt D.M., Rowlett J.K., Spealman R.D. Suppression of cocaine self-administration by D1 partial agonists. Soc. Neurosci. Abstr. 24:1998;2135.
66. Platt, D. M.; Spealman, R. D.; Rowlett, J. K.: Cocaine-antagonist properties of the D1 partial agonist SKF 83959 in squirrel monkeys. In: Problems of drug dependence 1998, NIDA Research Monograph. Washington, DC: U.S. Government Printing Office 179:178; 1999.
67. Preston K.L., Sullivan J.T., Strain E.C., Bigelow G.E. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J. Pharmacol. Exp. Ther. 262:1992;279-291.
68. Ranaldi R., Roberts D.C.S. Initiation, maintenance and extinction of cocaine self-administration with and without conditioned reward. Psychopharmacology (Berlin). 128:1996;89-96.
69. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Relationships among physiological and self-reported responses produced by cocaine-related cues. Addict. Behav. 22:1997;157-167.
70. Rohsenow D.J., Childress A.R., Monti P.M., Niaura R.S., Abrams D.B. Cue reactivity in addictive behaviors. Theoretical and treatment implications Int. J. Addict. 25:1990;957-993.
71. Schenk S., Worley C.M., McNamara C., Valadez A. Acute and repeated exposure to caffeine. Effects on reinstatement of extinguished cocaine-taking behavior in rats Psychopharmacology (Berlin). 126:1996;17-23.
72. Schuster C.R., Woods J.H. The conditioned reinforcing effects of stimuli associated with morphine reinforcement. Int. J. Addict. 3:1968;223-230.
73. 2-like dopamine receptor agonists. Science. 271:1996;1586-1589.
74. Self D.W., Genova L.M., Hope B.T., Barnhart W.J., Spencer J.J., Nestler E.J. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J. Neurosci. 18:1998;1848-1859.
75. Self D.W., Nestler E.J. Relapse to drug-seeking. Neural and molecular mechanisms Drug Alcohol Depend. 51:1998;49-60.
76. 1 agonists SKF 82958 and SKF 77434 are self-administered by rats. Brain Res. 582:1992;349-352.
77. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.-D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 17:1997;2605-2614.
78. Shaham Y., Stewart J. Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats. Psychopharmacology (Berlin). 125:1996;385-391.
79. Shiosaki K., Asin K.E., Britton D.R., Giardina W.J., Bednarz L., Mahan L., Mikusa J., Nikkel A., Wismer C. Hyperactivity and behavioral seizures in rodents following treatment with the dopamine D-1 receptor agonists A-86929 and ABT-431. Eur. J. Pharmacol. 317:1996;183-190.
80. Slikker W., Brocco M.J., Killam K.F. Reinstatement of responding maintained by cocaine or thiamylal. J. Pharmacol. Exp. Ther. 228:1984;43-52.
81. 2 receptor Eur. J. Pharmacol. 225:1992;331-337.
82. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
83. 3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys. J. Pharmacol. Exp. Ther. 278:1996;1128-1137.
84. Spealman R.D., Bergman J. Modulation of the discriminative stimulus effects of cocaine by mu and kappa opioids. J. Pharmacol. Exp. Ther. 261:1992;607-615.
85. Spealman R.D., Bergman J., Madras B.K., Melia K.C. Discriminative stimulus effects of cocaine in squirrel monkeys. Involvement of dopamine receptor subtypes J. Pharmacol. Exp. Ther. 258:1991;945-953.
86. 1 agonists. Psychopharmacology (Berlin). 133:1997;283-292.
87. Starr M.S. The role of dopamine in epilepsy. Synapse. 22:1996;159-194.
88. Stewart J. Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol. Biochem. Behav. 20:1984;917-923.
89. Stoner G.R., Skirboll L.R., Werkman S., Hommer D.W. Preferential effects of caffeine on limbic and cortical dopamine systems. Biol. Psychiatry. 23:1988;761-768.
90. Tennant F.S., Sagherian A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch. Intern. Med. 147:1987;109-112.
91. Vaillant G.E. Is there a natural history of addiction? O'Brien C.P., Jaffe J.H. Addictive states. 1992;41-57 Raven Press, New York.
92. Weddington W.W., Brown B.S., Haertzen C.A., Hess J.M., Mahaffey J.R., Kolar A.F., Jaffe J.H. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence. Am. J. Drug Alcohol Abuse. 17:1991;137-152.
93. Weed M.R., Paul I.A., Dwoskin L.P., Moore S.E., Woolverton W.L. The relationship between reinforcing effects and in vitro effects of D1 agonists in monkeys. J. Pharmacol. Exp. Ther. 283:1997;29-38.
94. 1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1367-1374.
95. Weissenborn R., Deroche V., Koob G., Weiss F. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology (Berlin). 126:1996;311-322.
96. Wikler A. Some implications of conditioning theory for problems of drug abuse. Behav. Sci. 16:1971;92-97.
97. Wise R.A., Murray A., Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berlin). 100:1990;355-360.
98. Wise R.A., Rompré P.-P. Brain dopamine and reward. Annu. Rev. Psychol. 40:1989;191-225.
99. Witkin J.M., Nichols D.E., Terry P., Katz J.L. Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J. Pharmacol. Exp. Ther. 257:1991;706-713.
100. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 229:1984;678-683.
101. Woolverton W.L., Johnson K.M. Neurobiology of cocaine abuse. Trends Pharmacol. Sci. 13:1992;193-200.
102. Worley C.A., Valadez A., Schenk S. Reinstatement of extinguished cocaine-taking behavior by cocaine and caffeine. Pharmacol. Biochem. Behav. 48:1994;217-221.